Patents by Inventor Ilana Kaspy

Ilana Kaspy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9133231
    Abstract: Rel proteins as a novel therapeutic agent for treating bacterial threats. More specifically, a novel class of compounds of Formula (I) as disclosed herein which possess antibacterial activity and which inhibit RelA, RelSeq or RelSpo synthetic activity or bacterial spore formation. Also, pharmaceutical compositions of such compounds and a method of combating bacteria, or treating bacterial infections, by administering to a subject in need thereof such compounds or pharmaceutical compositions.
    Type: Grant
    Filed: August 3, 2011
    Date of Patent: September 15, 2015
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Ezequiel Wexselblatt, Joshua Katzhendler, Ilana Kaspy, Gad Glaser, Roee Vidavski, Hafiz Mawasi, Sigal Ben Yehuda, Yaara Oppenheimer-Shaanan
  • Publication number: 20130203694
    Abstract: Rel proteins as a novel therapeutic agent for treating bacterial threats. More specifically, a novel class of compounds of Formula (I) as disclosed herein which possess anti-bacterial activity and which inhibit RelA, RelSeq or RelSpo synthetic activity or bacterial spore formation. Also, pharmaceutical compositions of such compounds and a method of combating bacteria, or treating bacterial infections, by administering to a subject in need thereof such compounds or pharmaceutical compositions.
    Type: Application
    Filed: August 3, 2011
    Publication date: August 8, 2013
    Applicant: YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Ezequiel Wexselblatt, Joshua Katzhendler, Gad Glaser, Sigal Ben Yehuda, Roee Vidavski, Hafiz Mawasi, Ilana Kaspy, Yaara Oppenheimer-Shaanan
  • Publication number: 20110086813
    Abstract: The present invention relates to a novel class of guanine nucleotide analogs which inhibit RelA and Relseq synthetic activity and which possess anti-bacterial activity. The present invention also relates to pharmaceutical compositions that include such compounds, and to methods of use of such compounds or compositions for combating bacteria and treating bacterial infections.
    Type: Application
    Filed: March 18, 2009
    Publication date: April 14, 2011
    Inventors: Gad Glaser, Jehoshua Katzhendler, Rolf Hilgenfeld, Roee Vidavski, Ezequiel Wexselblatt, Tamar Prez-Menahemov, Ilana Kaspy